Health-Related Legislation
S5755, an amendment (no. 603) introduced by Sen. McConnell (R-KY), to reform the health-care liability system and improve health-care quality through establishment of quality assurance programs, was agreed to by voice vote.
- S5755, an amendment (no. 603) introduced by Sen. McConnell(R-KY), to reform the health-care liability system and improvehealth-care quality through establishment of quality assuranceprograms, was agreed to by voice vote.
- S5793, an amendment (no. 605) introduced by Sen. Wellstone(D-MN), to revise provisions regarding reports on medical malpracticedata and access to certain information, was tabled by voice vote.
- S5800, an amendment (no. 608) introduced by Sen. Snowe (R-ME),to limit the amount of punitive damages that may be awarded ina health-care liability action, was agreed to by voice vote.
- S5931, an amendment (no. 611) introduced by Sen. Kyl (R-AZ),to place a limitation of $500,000 on noneconomic damages thatare awarded to compensate a claimant for pain, suffering, emotionaldistress, and other related injuries, was tabled by voice vote.
- H1566, a bill to amend the Internal Revenue Code to make permanentthe credit for clinical testing expenses for certain drugs andrare diseases or conditions was introduced by Rep. Johnson (R-CT).
Articles in this issue
ODAC Recommends Accelerated FDA Approval of Ethyol for Cytoprotection
House Panel Holds Hearing on Self-Referral
Health-Related Legislation
Mitoguazone Appears Promising in HIV-Associated Refractory NHL
Responses to Anti-HER2 MoAb Seen
NCI Committed to Increasing Minority Participation in Clinical Trials
MoAb May Improve Detection of Colon And Rectal Cancer
Zeneca Files NDA for Arimidex
Cord Blood is Used as Source of Stem Cells for Pediatric Transplantation
Gemcitabine/Cisplatin Shows Good Response Rate And Favorable Toxicity Profile in Advanced NSCLC
HCFA Needs to Do More to Prevent Medicare/Medicaid Fraud and Abuse
M.D. Anderson Holds First Cancer Meeting in Spanish
Molecular Markers Predict Clinical Outcome
NCAB Has Concerns About Future of Clinical Research
IP Interleukin-2 Shows Durable Responses in Ovarian Cancer
Recent Videos
